Targeting HDACs in Pancreatic Neuroendocrine Tumor Models

Lignende værker

• Targeting HDACs in Pancreatic Neuroendocrine Tumor Models
  af: Rosa Lynn Schmitz, et al.
  Udgivet: (2021-06-01)
• Impressive Response to TANDEM Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu/²²⁵AcDOTA-LM3 Somatostatin Receptor Antagonist in a Patient with Therapy-Refractory, Rapidly Progressive Neuroendocrine Neoplasm of the Pancreas
  af: Elisabetta Perrone, et al.
  Udgivet: (2024-04-01)
• Pathological complete response of initially unresectable multiple liver metastases achieved using combined peptide receptor radionuclide therapy and somatostatin analogs following pancreatic neuroendocrine tumor resection: a case report
  af: Ryosuke Umino, et al.
  Udgivet: (2024-02-01)
• Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus response
  af: Emilia Alors-Pérez, et al.
  Udgivet: (2024-03-01)
• Fibrosis markers as prognostic markers of decline in kidney function in patients with neuroendocrine neoplasms undergoing peptide receptor radionuclide therapy
  af: Tobias Stemann Lau, et al.
  Udgivet: (2025-06-01)